|
1
|
Wassef M, Upchurch GR Jr, Kuivaniemi H,
Thompson RW and Tilson MD III: Challenges and opportunities in
abdominal aortic aneurysm research. J Vasc Surg. 45:192–198. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lu H, Rateri DL, Bruemmer D, Cassis LA and
Daugherty A: Novel mechanisms of abdominal aortic aneurysms. Curr
Atheroscler Rep. 14:402–412. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Svensjö S, Björck M and Wanhainen A:
Editor's choice: Five-year outcomes in men screened for abdominal
aortic aneurysm at 65 years of age: A population-based cohort
study. Eur J Vasc Endovasc Surg. 47:37–44. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Y, Lu G, Sun D, Zuo H, Wang DW and Yan
J: Inhibition of endoplasmic reticulum stress signaling pathway: A
new mechanism of statins to suppress the development of abdominal
aortic aneurysm. PLoS One. 12:e01748212017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoshimura K, Aoki H, Ikeda Y, Fujii K,
Akiyama N, Furutani A, Hoshii Y, Tanaka N, Ricci R, Ishihara T, et
al: Regression of abdominal aortic aneurysm by inhibition of c-Jun
N-terminal kinase. Nat Med. 11:1330–1338. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kristensen KE, Torp-Pedersen C, Gislason
GH, Egfjord M, Rasmussen HB and Hansen PR: Angiotensin-converting
enzyme inhibitors and angiotensin II receptor blockers in patients
with abdominal aortic aneurysms: Nation-wide cohort study.
Arterioscler Thromb Vasc Biol. 35:733–740. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kent KC: Clinical practice. Abdominal
aortic aneurysms. N Engl J Med. 371:2101–2108. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shaulian E and Karin M: AP-1 as a
regulator of cell life and death. Nat Cell Biol. 4:E131–E136. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wisdom R, Johnson RS and Moore C: c-Jun
regulates cell cycle progression and apoptosis by distinct
mechanisms. EMBO J. 18:188–197. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shaulian E: AP-1-The Jun proteins:
Oncogenes or tumor suppressors in disguise? Cell Signal.
22:894–899. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hess J, Angel P and Schorpp-Kistner M:
AP-1 subunits: Quarrel and harmony among siblings. J Cell Sci.
117:5965–5973. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chinenov Y and Kerppola TK: Close
encounters of many kinds: Fos-Jun interactions that mediate
transcription regulatory specificity. Oncogene. 20:2438–2452. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Plotnikov A, Zehorai E, Procaccia S and
Seger R: The MAPK cascades: Signaling components, nuclear roles and
mechanisms of nuclear translocation. Biochim Biophys Acta.
1813:1619–1633. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu S, Gao J, Ohlemeyer C, Roos D, Niessen
H, Köttgen E and Gessner R: Activation of AP-1 through reactive
oxygen species by angiotensin II in rat cardiomyocytes. Free Radic
Biol Med. 39:1601–1610. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Frank GD, Eguchi S, Yamakawa T, Tanaka S,
Inagami T and Motley ED: Involvement of reactive oxygen species in
the activation of tyrosine kinase and extracellular
signal-regulated kinase by angiotensin II. Endocrinology.
141:3120–3126. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Friedman AD: GADD153/CHOP, a DNA
damage-inducible protein, reduced CAAT/enhancer binding protein
activities and increased apoptosis in 32D c13 myeloid cells. Cancer
Res. 56:3250–3256. 1996.PubMed/NCBI
|
|
17
|
Hotamisligil GS: Endoplasmic reticulum
stress and atherosclerosis. Nat Med. 16:396–399. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim I, Xu W and Reed JC: Cell death and
endoplasmic reticulum stress: Disease relevance and therapeutic
opportunities. Nat Rev Drug Discov. 7:1013–1030. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Oyadomari S and Mori M: Roles of
CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ.
11:381–389. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ubeda M, Vallejo M and Habener JF: CHOP
enhancement of gene transcription by interactions with Jun/Fos AP-1
complex proteins. Mol Cell Biol. 19:7589–7599. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guide for the Care and Use of Laboratory
Animals, . NIH Publication No. pp. 85–23. National Institutes of
Health; Bethesda, MD: 1996
|
|
22
|
Daugherty A, Manning MW and Cassis LA:
Angiotensin II promotes atherosclerotic lesions and aneurysms in
apolipoprotein E-deficient mice. J Clin Invest. 105:1605–1612.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Greene EL, Lu G, Zhang D and Egan BM:
Signaling events mediating the additive effects of oleic acid and
angiotensin II on vascular smooth muscle cell migration.
Hypertension. 37:308–312. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cominacini L, Garbin U, Mozzini C,
Stranieri C, Pasini A, Solani E, Tinelli IA and Pasini AF: The
atherosclerotic plaque vulnerability: Focus on the oxidative and
endoplasmic reticulum stress in orchestrating the macrophage
apoptosis in the formation of the necrotic core. Curr Med Chem.
22:1565–1572. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun Y, Zhang T, Li L and Wang J: Induction
of apoptosis by hypertension via endoplasmic reticulum stress.
Kidney Blood Press Res. 40:41–51. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qin Y, Wang Y, Liu O, Jia L, Fang W, Du J
and Wei Y: Tauroursodeoxycholic acid attenuates angiotensin ii
induced abdominal aortic aneurysm formation in apolipoprotein
E-deficient mice by inhibiting endoplasmic reticulum stress. Eur J
Vasc Endovasc Surg. 53:337–345. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zinszner H, Kuroda M, Wang X, Batchvarova
N, Lightfoot RT, Remotti H, Stevens JL and Ron D: CHOP is
implicated in programmed cell death in response to impaired
function of the endoplasmic reticulum. Genes Dev. 12:982–995. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Harding HP, Novoa I, Zhang Y, Zeng H, Wek
R, Schapira M and Ron D: Regulated translation initiation controls
stress-induced gene expression in mammalian cells. Mol Cell.
6:1099–1108. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vattem KM and Wek RC: Reinitiation
involving upstream ORFs regulates ATF4 mRNA translation in
mammalian cells. Proc Natl Acad Sci USA. 101:11269–11274. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dai DF, Johnson SC, Villarin JJ, Chin MT,
Nieves-Cintrón M, Chen T, Marcinek DJ, Dorn GW II, Kang YJ, Prolla
TA, et al: Mitochondrial oxidative stress mediates angiotensin
II-induced cardiac hypertrophy and Galphaq overexpression-induced
heart failure. Circ Res. 108:837–846. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chiu CZ, Wang BW and Shyu KG: Angiotensin
II and the JNK pathway mediate urotensin II expression in response
to hypoxia in rat cardiomyocytes. J Endocrinol. 220:233–246. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pyo R, Lee JK, Shipley JM, Curci JA, Mao
D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM and Thompson RW:
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase
B) suppresses development of experimental abdominal aortic
aneurysms. J Clin Invest. 105:1641–1649. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bi Y, Zhong H, Xu K, Zhang Z, Qi X, Xia Y
and Ren L: Development of a novel rabbit model of abdominal aortic
aneurysm via a combination of periaortic calcium chloride and
elastase incubation. PLoS One. 8:e684762013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ghoshal S and Loftin CD: Cyclooxygenase-2
inhibition attenuates abdominal aortic aneurysm progression in
hyperlipidemic mice. PLoS One. 7:e443692012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Trachet B, Fraga-Silva RA, Piersigilli A,
Tedgui A, Sordet-Dessimoz J, Astolfo A, Van der Donckt C, Modregger
P, Stampanoni MF, Segers P and Stergiopulos N: Dissecting abdominal
aortic aneurysm in Ang II-infused mice: Suprarenal branch ruptures
and apparent luminal dilatation. Cardiovasc Res. 105:213–222. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Browatzki M, Larsen D, Pfeiffer CA, Gehrke
SG, Schmidt J, Kranzhofer A, Katus HA and Kranzhofer R: Angiotensin
II stimulates matrix metalloproteinase secretion in human vascular
smooth muscle cells via nuclear factor-kappaB and activator protein
1 in a redox-sensitive manner. J Vasc Res. 42:415–423. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schubl S, Tsai S, Ryer EJ, Wang C, Hu J,
Kent KC and Liu B: Upregulation of protein kinase cdelta in
vascular smooth muscle cells promotes inflammation in abdominal
aortic aneurysm. J Surg Res. 153:181–187. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cai Z, Zhao G, Yan J, Liu W, Feng W, Ma B,
Yang L, Wang JA, Tu L and Wang DW: CYP2J2 overexpression increases
EETs and protects against angiotensin II-induced abdominal aortic
aneurysm in mice. J Lipid Res. 54:1448–1456. 2013. View Article : Google Scholar : PubMed/NCBI
|
